New York Medical College

Bio-Path Holdings Provides 2024 Clinical and Operational Update

Retrieved on: 
Tuesday, April 2, 2024
Toxicity, Obesity, Drug discovery, Chronic lymphocytic leukemia, Survival, CLL, AML, Fast track (FDA), Insulin, Patient, New York Medical College, Biomarker, Cancer, Leukemia, IND, University, Lymphoma, Pancreatic cancer, Clinical trial, Paclitaxel, Potential, Breast cancer, Safety, RNA interference, GRB2, Holding, Leptin, Probability, FDA, STAT3, Stage 4, Food, Pharmaceutical industry

HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today provides a clinical development and operational update for 2024.

Key Points: 
  • HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today provides a clinical development and operational update for 2024.
  • Prexigebersen Phase 2 Clinical Trial – Bio-Path’s Phase 2 clinical trial is treating Acute Myeloid Leukemia (AML) patients.
  • Phase 1/1b Clinical Trial in BP1002 in Relapsed/Refractory AML – A Phase 1/1b clinical trial for BP1002 to treat relapsed/refractory AML patients, including venetoclax-resistant patients, is ongoing.
  • In January 2024, Bio-Path announced successful completion of the first dose cohort in the Phase 1 clinical trial.

Dr. Rick "The RokDok" Brand: A Memoir of Resilience and Reinvention, from The Bronx to Rock Stardom and Beyond

Retrieved on: 
Tuesday, March 12, 2024
The Left Banke, Psychiatry, World War II, New York Medical College, Mental health, Phi Beta Kappa, Pretty Ballerina, Music, Multimedia, Medicine, CCNY

Brand unveils his gripping memoir, charting a course from being left back in high school to becoming a renowned psychiatrist, from the grooves of rock 'n' roll to the groves of academia.

Key Points: 
  • Brand unveils his gripping memoir, charting a course from being left back in high school to becoming a renowned psychiatrist, from the grooves of rock 'n' roll to the groves of academia.
  • Born in the shadow of World War II and raised in the rebellious streets of Greenwich Village, Rick Brand's tumultuous early life included brushes with academic failure and the law.
  • "This memoir isn't just my story; it's a roadmap for resilience and reinvention that I hope will resonate with anyone seeking to change their own narrative."
  • For more on Dr. Rick "The RokDok" Brand's life and his impact on mental health and rock 'n' roll, or for interviews, contact (914) 517-0226, [email protected] .

The Inner Circle acknowledges Mark J. Mills, JD, MD as a Life Achiever 2023-2024

Retrieved on: 
Monday, March 11, 2024
Harvard Law School, Geriatric psychiatry, Harvard Medical School, University, Philosophy, American Psychiatric Association, Forensic psychiatry, Private practice, New York Medical College, Distinguishing, Columbia University, Distinguished Service Award, Law, MD, American College, Society, Absence, Stanford University, Multimedia, Inner circle, JD, Bronze medal

RALEIGH, N.C., March 11, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mark J.

Key Points: 
  • RALEIGH, N.C., March 11, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mark J.
  • Mills, JD, MD is acknowledged as a Life Achiever 2023-2024 for his contributions as a Forensic Psychiatrist.
  • Mills, a highly accomplished forensic psychiatrist, is marking an impressive 48 years of dedication and expertise in the field of forensic psychiatry.
  • As a renowned figure in the industry, Dr. Mills has made substantial contributions to academia and has maintained a thriving private firm, Mark J.

AOFAS Honors Two Female Orthopaedic Leaders

Retrieved on: 
Tuesday, February 27, 2024
Stamford Hospital, Treace Medical Concepts, Breast cancer, Cancer, Weill Cornell Medicine, Woman, Copy, Ankle, Medical school, Assistant, Physician, Hospital, Female, Fluoroscopy, Surgeon, NewYork-Presbyterian Hospital, Orthopedic surgery, Radiation, Risk, Stanford University, Breast, Prevalence, Operating, Knowledge, New York Medical College, Male, Publication, DRS, Research, Dentistry

“I am proud that AOFAS is making an effort to recognize women in foot and ankle orthopaedic surgery.”

Key Points: 
  • “I am proud that AOFAS is making an effort to recognize women in foot and ankle orthopaedic surgery.”
    Over the past 15 years, Dr. Chou has conducted several research studies to examine breast cancer prevalence among female orthopaedic surgeons.
  • Dr. Chou’s research results confirmed higher breast cancer prevalence among female orthopaedic surgeons than the general population, and in a later study, she discovered higher prevalence among female orthopaedic surgeons compared to women in other surgical specialties.
  • Currently, she is leading a study to evaluate cancer risk associated with radiation exposure in male and female orthopaedic surgeons.
  • I applaud AOFAS for taking that initiative with these awards.”
    Funding for the AOFAS Women’s Leadership Initiative is provided by the Orthopaedic Foot & Ankle Foundation, supported by a grant from Treace Medical Concepts, Inc.

The Inner Circle Acknowledges, Stephanie E. Gore as a Top Pinnacle Professional

Retrieved on: 
Monday, February 26, 2024
Professional, Inner circle, University, Multimedia, Physician, ABOG, Female, Public health, Fellow, American Medical Association, Health, Obstetrics, Northern Westchester Hospital, University of Arizona, Puberty, National Medical Association, American College, Patient, Family, Knowledge, New York Medical College, Nursing

BRONX, N.Y., Feb. 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Stephanie E. Gore is acknowledged as a Top Pinnacle Professional for her contributions to the Obstetrics and Gynecology Fields.

Key Points: 
  • BRONX, N.Y., Feb. 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Stephanie E. Gore is acknowledged as a Top Pinnacle Professional for her contributions to the Obstetrics and Gynecology Fields.
  • Dr. Gore began her educational journey at The University of Arizona where she earned a Bachelor of Science degree.
  • She capped her scholarship by completing an internship and residency at New York Medical College.
  • Dr. Gore delivers babies and has a comprehensive gynecologic practice focusing on robotic laparoscopic surgeries and traditional surgical procedures.

Neurelis to Host Virtual Pipeline Update to Discuss Advancements Addressing Unmet Needs in Neuroscience on March 7, 2024

Retrieved on: 
Monday, February 26, 2024
FACS, Master of Science, ROCK, Olanzapine, University, Patient, MPH, New York Medical College, Hemangioma, Doctor of Psychology, Pharmaceutical industry

The investor call will be held virtually on Thursday, March 7, 2024 at 10:30 AM ET.

Key Points: 
  • The investor call will be held virtually on Thursday, March 7, 2024 at 10:30 AM ET.
  • To register, click here.
  • NRL-1004, an investigational nasal spray formulation of olanzapine and Neurelis proprietary Intravail® technology, for the treatment of acute agitation episodes, featuring Leslie Lucien Citrome, MD, MPH (New York Medical College, SUNY Upstate Medical University, Icahn School of Medicine at Mount Sinai).
  • A live question and answer session will follow the formal presentations of both segments.

Unveiling Tomorrow's Medical Pioneers: The Dr. Stephen Carolan Scholarship for Medical Students Embarks on a Journey of Excellence

Retrieved on: 
Friday, February 16, 2024
Gynaecology, Health, New York Medical College, Saint John's University, Education, Greenwich Hospital

RYE, N.Y., Feb. 16, 2024 /PRNewswire/ -- Dr. Stephen Carolan , a beacon of inspiration in the realm of healthcare, proudly introduces the illustrious Dr. Stephen Carolan Scholarship for Medical Students.

Key Points: 
  • RYE, N.Y., Feb. 16, 2024 /PRNewswire/ -- Dr. Stephen Carolan , a beacon of inspiration in the realm of healthcare, proudly introduces the illustrious Dr. Stephen Carolan Scholarship for Medical Students.
  • The Dr. Stephen Carolan Scholarship stands as a testament to Dr. Carolan's unwavering commitment to excellence and his passion for advancing healthcare.
  • Dr. Stephen Carolan , the visionary behind this transformative scholarship, has left an indelible mark on the medical community.
  • For more information about the Dr. Stephen Carolan Scholarship for Medical Students and to submit an application, please visit https://drstephencarolanscholarship.com/dr-stephen-carolan-scholarship/ .

SightMD Welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD

Retrieved on: 
Friday, January 19, 2024
Eye, Patient, Amblyopia, TBI, State university system, Infection, Contact, Diagnosis, Glasses, Yale School of Medicine, Strabismus, Paratriathlon, Allergy, Three-body problem, Brain, OD, Brown University, New York Medical College, Illinois College

HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.

Key Points: 
  • SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • HAUPPAUGE, N.Y., Jan. 19, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Andrew Garcia, MD, Jeremy Liang, OD and Brian Berliner, OD to its expert team.
  • Jeremy Liang, OD is a board-certified optometrist providing dilated exams, contact lenses and eyeglasses, dry eye treatments, and more.
  • Brian Berliner, OD is a board certified optometrist who has been practicing and providing eye care since 1983.

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

Retrieved on: 
Wednesday, January 10, 2024
BH3, Patient, Associate, CLL, RNA, RNA interference, Cancer, Safety, University, AML, New York Medical College, Holding

High expression of Bcl-2 has been correlated with adverse prognosis for patients diagnosed with relapsed, aggressive non-Hodgkin’s lymphoma.

Key Points: 
  • High expression of Bcl-2 has been correlated with adverse prognosis for patients diagnosed with relapsed, aggressive non-Hodgkin’s lymphoma.
  • In the Phase 1 trial, refractory/relapsed CLL patients, including those who have failed or relapsed from venetoclax-based frontline therapy, as well as refractory/relapsed lymphoma patients, will be treated with BP1002.
  • As a result, Bio-Path believes that BP1002 could provide an alternative treatment for venetoclax refractory/relapsed CLL patients.
  • The primary objective of the study is to evaluate the safety and tolerability of escalating doses of BP1002.

BrainCheck Appoints Aaron Greenstein, MD to Clinical Advisory Board

Retrieved on: 
Monday, January 8, 2024
Report, Dementia, Caregiver, The Wall Street Journal, Research, McLean Hospital, Geriatric psychiatry, Massachusetts General Hospital, Ageing, MD, New York Medical College, CO, Human services, Mass, Mass General Brigham, Harvard Review of Psychiatry, Growth, Patient, MGH, News, Policy, Nursing

AUSTIN, Texas, Jan. 8, 2024 /PRNewswire/ -- BrainCheck, Inc. announced the appointment of Aaron Greenstein, MD, a distinguished, board-certified geriatric psychiatrist specializing in geriatric mental illness and dementia, to its clinical advisory board, enhancing the Company's clinical leadership and expertise. Dr. Greenstein, who has worked for some of the most prestigious academic facilities and influential senior healthcare startups, joins the Company as Clinical Advisor following the recent launch of its next-generation platform and 3-minute screening tool, expanding the first end-to-end solution for cognitive care.

Key Points: 
  • AUSTIN, Texas, Jan. 8, 2024 /PRNewswire/ -- BrainCheck, Inc. announced the appointment of Aaron Greenstein, MD, a distinguished, board-certified geriatric psychiatrist specializing in geriatric mental illness and dementia, to its clinical advisory board, enhancing the Company's clinical leadership and expertise.
  • "Dr. Greenstein's expertise will be invaluable as we continue to innovate and strengthen our offerings to better serve healthcare professionals, patients, and caregivers," said Kim Rodriguez, CEO of BrainCheck.
  • "In previous roles, Dr. Greenstein led objective evaluations of available cognitive assessment and care planning tools, and concluded that BrainCheck has the highest clinical utility and efficacy.
  • His research validates the clinical utility of our technology and we look forward to continuing to incorporate his expert acumen as we evolve our solutions and accelerate nationwide adoption."